The report, conducted by the Council of Economic Advisers, said the prescription drug component of the consumer price index indicated that drug prices were rising more slowly than general price inflation.
It argued that some recent news stories are misleading because they rely on wholesale prices that don’t reflect what consumers pay.
The report also said the data cited by the media may not capture more commonly used drugs like lower-cost generics.
However, the consumer price index cited in the report does not account for all medicines, according to STAT. It only includes prices for drugs available at the pharmacy and excludes the more expensive, physician-administered medicines.
The report comes as the Trump administration has failed to deliver on promises such as eliminating rebates in government healthcare programs and requiring drugmakers to advertise list prices in direct to consumer TV ads.
Read the full article here.
More articles on pharmacy:
Eli Lilly and Bayer dodge suits claiming they used nurses to push drugs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
